Glucotrack (GCTK) Total Current Liabilities (2010 - 2025)
Glucotrack's (GCTK) quarterly Total Current Liabilities came in at $4.8 million in Q4 2025, up 274.35% YoY from $1.3 million in Q4 2024, and down 9.89% on a QoQ basis from $5.3 million in Q3 2025.
Glucotrack (GCTK) Total Current Liabilities (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 16 years of Total Current Liabilities data on file, last reported at $4.8 million in Q4 2025.
- Quarterly Total Current Liabilities rose 274.35% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 274.35% YoY) and the FY2025 annual result came in at $4.8 million, up 274.35% from the prior year.
- Total Current Liabilities eased to $4.8 million in Q4 2025, from $5.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $5.3 million in Q3 2025 to a low of $883000.0 in Q4 2021.
- A 5-year average of $2.0 million and a median of $1.3 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities slumped 37.09% — and 2025, when it soared 274.35%.
- Tracing GCTK's Total Current Liabilities over 5 years: stood at $883000.0 in 2021, then rose by 14.72% to $1.0 million in 2022, then jumped by 49.26% to $1.5 million in 2023, then decreased by 15.67% to $1.3 million in 2024, then soared by 274.35% to $4.8 million in 2025.
- The last three Total Current Liabilities figures came in at $4.8 million (Q4 2025), $5.3 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Glucotrack | 1.73 Mn | 607,139.82 | - | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 3.66 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 965,000.00 |
| Jun 30, 2022 | 935,000.00 |
| Mar 31, 2022 | 916,000.00 |
| Dec 31, 2021 | 883,000.00 |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 1.25 Mn |